The PancreasGroup.org team is conducting a "snapshot" clinical study investigating the outcomes of pancreatic surgery worldwide. This "collaborative" model for snapshot clinical studies is a well-established approach for assessing current practice in a short period of time.
There will be 3 months of prospective enrolment and 3 months follow up within a 12-month frame. The study will provide highly valuable data on outcomes after pancreatic surgery.
The investigators are aiming at providing a verified record of true morbidity and mortality in consecutive unselected patients. This way the investigators will help identify relevant, modifiable predicting factors for outcome after pancreatic surgery.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
All indications (including benign and malignant)
Open, laparoscopic or robotic.
Elective or emergency.
Partial or total pancreatectomies.
Pancreatic tumour enucleations.
Procedures with concomitant vascular or other organ resections.
Pancreatic duct drainage procedures (e.g. Frey, Puestow, or Beger)
Adults 18 years of age or older.
You may not be if
Pancreas or islet cell transplantation.
Transcutaneous or transgastric imaging-guided ablation (e.g. RFA) or electroporation (e.g. NanoKnife).
Endoscopic (e.g. endoscopic retrograde cholangiopancreatography, stent or lithotripsy) procedures.
Endoscopic transgastric and surgical necrosectomies excluded.
Patients less than 18 years of age excluded.
Clareo Health | International Pancreatic Surgery Outcomes Study - PancreasGroup.Org
